Our science
Our scientists do more than imagine the future — they create it. The pipeline at Bristol Myers Squibb encompasses differentiated research platforms across hematology, oncology, immunology, cardiovascular disease and neuroscience. It offers a uniquely diverse and broad toolbox of modalities rooted in causal human biology to help realize our vision of transforming patient’s lives through science.
Our dedicated scientists around the world are driven by a pioneering spirit, often being among the first to explore and succeed in complex approaches, to create life-changing medicines for patients. We're making strides with a range of powerful approaches, including cell therapy, targeted protein degradation, radiopharmaceuticals, advanced small molecules and biotherapeutics. We concentrate on areas where there are few treatment options or where we can set a new standard of care, aiming to make a significant difference in patients' lives.
Every new medicine starts with a solid research foundation. We identify key disease-causing targets based on our knowledge of causal human biology, and are then able to match the best modality, or treatment approach, from our wide range of options to effectively address these targets. We strive to make sure our research smoothly transitions into development by proving the concept and its potential in clinical settings. By combining this strategy with cutting-edge technology, we work quickly and efficiently to deliver new, life-changing medicines to patients worldwide.
From our leaders
Read how our leaders are driving innovation for patients, setting Bristol Myers Squibb apart.
Join us as we transform patients live through science
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. As global citizens, we work sustainably and responsibly to create a positive impact in the communities where we live and work.
